Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 288

1.

Circulating serum microRNA (miR-367-3p, miR-371a-3p, miR-372-3p, miR-373-3p) as biomarkers for patients with testicular germ cell cancers.

Syring I, Bartels J, Holdenrieder S, Kristiansen G, Müller SC, Ellinger J.

J Urol. 2014 Jul 18. pii: S0022-5347(14)03957-3. doi: 10.1016/j.juro.2014.07.010. [Epub ahead of print]

PMID:
25046619
[PubMed - as supplied by publisher]
2.

Histopathological screening for prostate carcinoma: is a benign biopsy a negative biopsy?

Sailer V, Kristiansen G.

APMIS. 2014 Aug;122(8):690-8. doi: 10.1111/apm.12291.

PMID:
25046199
[PubMed - in process]
3.

KDM5C Is Overexpressed in Prostate Cancer and Is a Prognostic Marker for Prostate-Specific Antigen-Relapse Following Radical Prostatectomy.

Stein J, Majores M, Rohde M, Lim S, Schneider S, Krappe E, Ellinger J, Dietel M, Stephan C, Jung K, Perner S, Kristiansen G, Kirfel J.

Am J Pathol. 2014 Sep;184(9):2430-7. doi: 10.1016/j.ajpath.2014.05.022. Epub 2014 Jul 9.

PMID:
25016185
[PubMed - in process]
4.

CD57 expression in incidental, clinically manifest, and metastatic carcinoma of the prostate.

Wangerin H, Kristiansen G, Schlomm T, Stephan C, Gunia S, Zimpfer A, Weichert W, Sauter G, Erbersdobler A.

Biomed Res Int. 2014;2014:356427. doi: 10.1155/2014/356427. Epub 2014 May 22.

PMID:
24977150
[PubMed - in process]
Free PMC Article
5.

Expression of vasoactive proteins in gastric antral mucosa reflects vascular dysfunction in patients with cirrhosis and portal hypertension.

Trebicka J, Wix C, von Heydebrand M, Hittatiya K, Reiberger T, Klein S, Schierwagen R, Kristiansen G, Peck-Radosavljevic M, Fischer HP, Møller S, Bendtsen F, Krag A, Sauerbruch T.

Liver Int. 2014 Jun 10. doi: 10.1111/liv.12613. [Epub ahead of print]

PMID:
24912856
[PubMed - as supplied by publisher]
6.

Molecular stratification of medulloblastoma: Comparison of histological and genetic methods to detect Wnt activated tumors.

Goschzik T, Zur Mühlen A, Kristiansen G, Haberler C, Stefanits H, Friedrich C, von Hoff K, Rutkowski S, Pfister SM, Pietsch T.

Neuropathol Appl Neurobiol. 2014 Jun 4. doi: 10.1111/nan.12161. [Epub ahead of print]

PMID:
24894640
[PubMed - as supplied by publisher]
7.

Nucleic acid-based tissue biomarkers of urologic malignancies.

Dietrich D, Meller S, Uhl B, Ralla B, Stephan C, Jung K, Ellinger J, Kristiansen G.

Crit Rev Clin Lab Sci. 2014 Aug;51(4):173-99. doi: 10.3109/10408363.2014.906130. Epub 2014 May 30.

PMID:
24878394
[PubMed - in process]
8.

Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies.

Ralla B, Stephan C, Meller S, Dietrich D, Kristiansen G, Jung K.

Crit Rev Clin Lab Sci. 2014 Aug;51(4):200-31. doi: 10.3109/10408363.2014.914888. Epub 2014 May 30.

PMID:
24878357
[PubMed - in process]
9.

Loss of anterior gradient-2 expression is an independent prognostic factor in colorectal carcinomas.

Riener MO, Thiesler T, Hellerbrand C, Amann T, Cathomas G, Fritzsche FR, Dahl E, Bahra M, Weichert W, Terracciano L, Kristiansen G.

Eur J Cancer. 2014 Jul;50(10):1722-30. doi: 10.1016/j.ejca.2014.04.012. Epub 2014 Apr 30.

PMID:
24794000
[PubMed - indexed for MEDLINE]
10.

Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinoma.

Schröck A, Bode M, Göke FJ, Bareiss PM, Schairer R, Wang H, Weichert W, Franzen A, Kirsten R, van Bremen T, Queisser A, Kristiansen G, Heasley L, Bootz F, Lengerke C, Perner S.

Carcinogenesis. 2014 Jul;35(7):1636-42. doi: 10.1093/carcin/bgu094. Epub 2014 Apr 17.

PMID:
24743512
[PubMed - in process]
11.

Performance evaluation of kits for bisulfite-conversion of DNA from tissues, cell lines, FFPE tissues, aspirates, lavages, effusions, plasma, serum, and urine.

Holmes EE, Jung M, Meller S, Leisse A, Sailer V, Zech J, Mengdehl M, Garbe LA, Uhl B, Kristiansen G, Dietrich D.

PLoS One. 2014 Apr 3;9(4):e93933. doi: 10.1371/journal.pone.0093933. eCollection 2014.

PMID:
24699908
[PubMed - in process]
Free PMC Article
12.

Expression of histone deacetylases 1, 2 and 3 in urothelial bladder cancer.

Poyet C, Jentsch B, Hermanns T, Schweckendiek D, Seifert HH, Schmidtpeter M, Sulser T, Moch H, Wild PJ, Kristiansen G.

BMC Clin Pathol. 2014 Mar 13;14(1):10. doi: 10.1186/1472-6890-14-10.

PMID:
24624923
[PubMed]
Free PMC Article
13.

Variation in reporting of cancer extent and benign histology in prostate biopsies among European pathologists.

Berney DM, Algaba F, Camparo P, Compérat E, Griffiths D, Kristiansen G, Lopez-Beltran A, Montironi R, Varma M, Egevad L.

Virchows Arch. 2014 May;464(5):583-7. doi: 10.1007/s00428-014-1554-1. Epub 2014 Mar 4.

PMID:
24590584
[PubMed - indexed for MEDLINE]
14.

Reproducibility of histopathologic tumor grading in penile cancer--results of a European project.

Kakies Ch, Lopez-Beltran A, Comperat E, Erbersdobler A, Grobholz R, Hakenberg OW, Hartmann A, Horn LC, Höhn AK, Köllermann J, Kristiansen G, Montironi R, Scarpelli M, Protzel Ch.

Virchows Arch. 2014 Apr;464(4):453-61. doi: 10.1007/s00428-014-1548-z. Epub 2014 Feb 18.

PMID:
24535700
[PubMed - indexed for MEDLINE]
15.

GNAS sequencing identifies IPMN-specific mutations in a subgroup of diminutive pancreatic cysts referred to as "incipient IPMNs".

Matthaei H, Wu J, Dal Molin M, Shi C, Perner S, Kristiansen G, Lingohr P, Kalff JC, Wolfgang CL, Kinzler KW, Vogelstein B, Maitra A, Hruban RH.

Am J Surg Pathol. 2014 Mar;38(3):360-3. doi: 10.1097/PAS.0000000000000117.

PMID:
24525507
[PubMed - indexed for MEDLINE]
16.

Serum microRNAs as biomarkers in patients undergoing prostate biopsy: results from a prospective multi-center study.

Westermann AM, Schmidt D, Holdenrieder S, Moritz R, Semjonow A, Schmidt M, Kristiansen G, Müller SC, Ellinger J.

Anticancer Res. 2014 Feb;34(2):665-9.

PMID:
24510997
[PubMed - indexed for MEDLINE]
17.

Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusions.

Dietrich D, Jung M, Puetzer S, Leisse A, Holmes EE, Meller S, Uhl B, Schatz P, Ivascu C, Kristiansen G.

PLoS One. 2013 Dec 27;8(12):e84225. doi: 10.1371/journal.pone.0084225. eCollection 2013.

PMID:
24386354
[PubMed - in process]
Free PMC Article
18.

Analysis of TET expression/activity and 5mC oxidation during normal and malignant germ cell development.

Nettersheim D, Heukamp LC, Fronhoffs F, Grewe MJ, Haas N, Waha A, Honecker F, Waha A, Kristiansen G, Schorle H.

PLoS One. 2013 Dec 26;8(12):e82881. doi: 10.1371/journal.pone.0082881. eCollection 2013.

PMID:
24386123
[PubMed - in process]
Free PMC Article
19.

MED15, encoding a subunit of the mediator complex, is overexpressed at high frequency in castration-resistant prostate cancer.

Shaikhibrahim Z, Menon R, Braun M, Offermann A, Queisser A, Boehm D, Vogel W, Rüenauver K, Ruiz C, Zellweger T, Svensson M, Andren O, Kristiansen G, Wernert N, Bubendorf L, Kirfel J, Biskup S, Perner S.

Int J Cancer. 2014 Jul 1;135(1):19-26. doi: 10.1002/ijc.28647. Epub 2013 Dec 9.

PMID:
24374838
[PubMed - indexed for MEDLINE]
20.

SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer.

Hoefer J, Kern J, Ofer P, Eder IE, Schäfer G, Dietrich D, Kristiansen G, Geley S, Rainer J, Gunsilius E, Klocker H, Culig Z, Puhr M.

Endocr Relat Cancer. 2014 Jan 30;21(2):175-87. doi: 10.1530/ERC-13-0446. Print 2014 Apr.

PMID:
24280133
[PubMed - in process]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk